Browse > Article

cAMP-response Element-binding Protein Is not Essential for Osteoclastogenesis Induced by Receptor Activator of NF-${\kappa}B$ Ligand  

Kim, Ha-Neui (Department of Cell and Developmental Biology, DRI, BK21 Program, School of Dentistry, Seoul National University)
Ha, Hyun-Il (Department of Cell and Developmental Biology, DRI, BK21 Program, School of Dentistry, Seoul National University)
Lee, Jong-Ho (Department of Cell and Developmental Biology, DRI, BK21 Program, School of Dentistry, Seoul National University)
Kwak, Han-Bok (Department of Cell and Developmental Biology, DRI, BK21 Program, School of Dentistry, Seoul National University)
Kim, Hong-Hee (Department of Cell and Developmental Biology, DRI, BK21 Program, School of Dentistry, Seoul National University)
Lee, Zang-Hee (Department of Cell and Developmental Biology, DRI, BK21 Program, School of Dentistry, Seoul National University)
Publication Information
International Journal of Oral Biology / v.30, no.4, 2005 , pp. 143-148 More about this Journal
Abstract
Osteoclasts are multinucleated cells with bone resorbing activity and differentiated from hematopoietic cell lineages of monocyte/macrophages in the presence of receptor activator of NF-${\kappa}B$ ligand (RANKL) and M-CSF. However, the exact molecular mechanisms through which RANKL stimulates osteoclastogenesis remain to be elucidated. Here we report that activation of cAMP-response elementbinding protein (CREB) is not involved in osteoclastogenesis from osteoclast precursors in response to RANKL. RANKL induced CREB activation in osteoclast precursors. Using pharmacological inhibitors, we found that RANKL-induced CREB activation is dependent on p38 MAPK pathways. We also found that ectopic expressions of wild type and dominant negative forms of CREB in osteoclast precursors did not affect RANKL-induced osteoclast formation and bone resorbing activity. Furthermore, dominant negative forms of CREB did not alter the expression levels of osteoclast-specific marker genes. Taken together, these data suggest that CREB is dispensable for differentiation and resorbing activity of osteoclasts.
Keywords
Osteoclast; RANKL; CREB;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Arias, J., Alberts, A.S., Brindle, P., Claret, F.X., Smeal, T., Karin, M., Feramisco, J. and Montmany, M.: Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature 370:226-228, 1994   DOI   ScienceOn
2 Muthusamy, N. and Leiden, J.M.: A protein kinase C-, ras-, and RSK2-dependent signal transduction pathway activates the cAMP-responsive element-binding protein transcription factor following T cell receptor engagement. J. Biol. Chem. 273:841-847, 1998   DOI   PUBMED   ScienceOn
3 Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M.T. and Martin, T.J.: Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20:345-357, 1999   DOI   ScienceOn
4 Zhang, W. and Liu, H.T.: MAPK signal pathway in the regulation of cell proliferation in mammalian cells. Cell Res. 12:9-18, 2002   DOI   ScienceOn
5 Ha, H., Kwak, H.B., Lee, S.W., Jin, H.M. Kim, H.M., Kim, H.H. and Lee, Z.H.: Reactive oxygen species mediate RANK signaling in osteoclasts. Exp. Cell Res. 301:119-127, 2004   DOI   ScienceOn
6 Teitelbaum, S.L. and Ross, F.P.: Genetic regulation of osteoclast development and function. Nat. Rev. Genet. 4:638-649, 2003   DOI   ScienceOn
7 Mayr, B. and Montminy, M.: Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev. Mol. Cell. Biol. 2:599-609, 2001   DOI   ScienceOn
8 Edwards, D.R.: Cell signaling and the control of gene transcription. Trends Pharmacol. Sci. 15:239-244, 1994   DOI   PUBMED   ScienceOn
9 Tan, Y., Rouse J., Zhang A., Cariati, S., Cohen, P. and Comb, M.J.: FGF and stress regulate CREB and ATF-l via a pathway involving p38 MAP kinase and MAPKAP kinase2. EMBO J. 15:4629-4642, 1996
10 Kwok, R.P., Lundblad, Jr., Chrivia, J.C., Richards, J.P., Bachinger, H.P., Brennan, R.G., Roberts, S.G., Green, M.R. and Goodman, R.H.: Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 370:223-226, 1994   DOI   ScienceOn
11 Sun, P., Enslen, H., Myung, P.S. and Maurer, R.A.: Differential activation of CREB by $Ca^2^+$/calmodulin-dependent protein kinases type II and type IV involves phosphorylation of a site that negatively regulates activity. Genes Dev. 8:2527-2539, 1994   DOI   ScienceOn
12 Karsenty, G. and Wagner, E.F.: Reaching a genetic and molecular understanding of skeletal development. Dev. Cell 2:389-406, 2002   DOI   ScienceOn
13 Tanaka, S., Nakamura, K., Takahasi, N. and Suda, T.: Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system. Immunol. Rev. 208:30-49, 2005   DOI   ScienceOn
14 Reusch, J.E., Colton, L.A. and Klemm, D.J.: CREB activation induces adipogenesis in 3T3-Ll cells. Mol. Cell. Biol. 20:1008-1020. 2000   DOI   ScienceOn
15 Barton, H., Muthusamy, M., Chanyangam, C., Fischer, C., Cledenin, C. and Leiden, J. M.: Defective thymocyte proliferation and IL-2 production in transgenic mice expressing a dominant-negative form of CREB. Nature 379:81-85, 1996   DOI   ScienceOn
16 Kobayashi, K., Takahashi, N., Jimi, E., Udagawa, N., Takami, M., Kotake, S., Nakagawa, N., Kinosaki, M., Yamaguchi, K., Shima, N., Yasuda, H., Morinaga, T., Higashio, K., Martin, T.J. and Suda, T.: Tumor necrosis factor-$\alpha$ stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J. Exp. Med. 191:275-285, 2000   DOI
17 Udagawa, N., Takahashi, N. and Akatsu, T.: Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc. Natl. Acad. Sci. USA 87:7260-7264, 1990   DOI
18 Du, K. and Montminy, M.: CREB is a regulatory target for the protein kinase Akt/PKB. J. Biol. Chem. 273:32377-32379, 1998   DOI   ScienceOn
19 Suda, T., Takahashi, N. and Martin, T.J.: Modulation of osteoclast differentiation. Endocr. Rev. 13:66-80, 1992   DOI   PUBMED
20 Matsumoto, M., Kogawa, M., Wada, S., Takayanagi, H., Tsujimoto, M., Katayama, S., Hisatake, K. and Nogi, Y.: Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATcl and PU.1. J. Biol. Chem. 279:45969-45979, 2004   DOI   ScienceOn
21 Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., Tsuda, E., Morinaga, T., Higashio, K., Udagawa, N., Takahashi, N. and Suda, T.: Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and identical to TRANCE-RANKL. Proc. Natl. Acad. Sci. USA 95:3579-3602, 1998   DOI
22 Ahn, S., Olive, M., Aggarwal, S., Krylov, D., Ginty, D.D. and Vinson, C.: A dominant-negative inhibitor of CREB reveals that it is a general mediator of stimulus-ependent transcription of c-fos. Mol. Cell. Biol. 18:967-977, 1998
23 Bernhard, M. and Marc, M.: Transcriptional regulation by the phosphorylation-dependent factor CREB. Nature Rev. 2:599-609, 2001   DOI   ScienceOn
24 Brindle, P., Linke, S. and Montminy, M.: Protein-kinase-Adependent activator in transcription factor CREB reveals new role for CREM repressors. Nature 364:821-824, 1993   DOI   ScienceOn
25 Johnson, G.L. and Vaillancourt, R.R: Sequential protein kinase reactions controlling cell growth and differentiation. Curr. Opin. Cell Biol. 6:230-238, 1994   DOI   ScienceOn
26 Rodan, G.A. and Martin, T.J.: Therapeutic approaches to bone diseases. Science 289:1508-1514, 2000   DOI   PUBMED
27 Gonzalez, G.A. and Montminy, M.R.: Cyclic AMP stimulates somatostatin genetranscription by phosphorylation of CREB at serine 133. Cell 59:675-680, 1989   DOI   ScienceOn
28 Habener, J.F.: Cyclic AMP response element binding proteins: a cornucopia of transcription factors. Mol. Endocrinol. 4:1087-1094, 1990   DOI   ScienceOn
29 Hoeffler, J.P., Meyer, T.E., Yun, Y., Jameson, J.L. and Habener, J.F.: Cyclic AMP-responsive DNA-binding protein: structure based on a cloned placental cDNA. Science 242:1430-1433, 1988   DOI   PUBMED
30 Anderson, D.M., Maraskovsky, E., Billingsley, W.L., Dougall, W.C., Tometsko, M.E., Roux, E.R., Teepe, M.C., DuBose, R.F., Cosman, D. and Galibert, L.A.: Homologue ofthe TNF receptor and its ligand enhance T-cell growth and dendriticcell function. Nature 390:175-195, 1997   DOI   PUBMED   ScienceOn
31 Takahashi, N., Udagawa, N. and Suda, T.: A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function. Biochem. Biophys. Res. Commun. 256:449-455, 1999   DOI   ScienceOn
32 Seger, R. and Krebs, E.G.: The MAPK signaling cascade. FASEB J 9:726-735, 1995
33 Gonzalez, G.A., Yamamoto, K.K., Fischer, W.H., Karr, D., Menzel, P., Biggs, W., Vale, W.W. and Montminy, M.R.: A cluster of phosphorylation sites on the cyclic AMP-regulated nuclear factor CREB predicted by its sequence. Nature 337:749-752, 1989   DOI   ScienceOn
34 Woloshin, P., Walton, K., Rehfuss, R., Goodman, R. and Cone, R.: CREB activity is required for normal growth and differentiated phenotype in the FRTL5 thyroid follicular cell line. Mol Endocrinol 5:1725-1733, 1992   DOI   PUBMED   ScienceOn